UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Psychosocial factors associated with pharmacists’ end-of-life medication counseling and dispensing

Journal of the American Pharmacists Association, 2021-11, Vol.61 (6), p.e1-e1

Irwin, Adriane N.

2021

Volltextzugriff (PDF)

Educational Approach to Increase Student Pharmacist Confidence with Medicare

Innovations in pharmacy, 2021-03, Vol.12 (1), p.22

Irwin, Adriane N

2021

Volltextzugriff (PDF)

Assessing provider knowledge of the federal 340B Drug Pricing Program in a federally qualified health center

American journal of health-system pharmacy, 2024-04

2024

Volltextzugriff (PDF)

Characterization of kratom use and knowledge at a rural, Oregon community health center

Journal of the American Pharmacists Association, 2024-09, Vol.64 (5), p.102138-102138, Article 102138

2024

Volltextzugriff (PDF)

Comparison of the time-to-indexing in PubMed between biomedical journals according to impact factor, discipline, and focus

Research in social and administrative pharmacy, 2017-03, Vol.13 (2), p.389-393

2017

Volltextzugriff (PDF)

Community pharmacies embedded within student health centers on college and university campuses: A cross-sectional survey

Journal of the American Pharmacists Association, 2020-11, Vol.60 (6), p.e184-e189

2020

Volltextzugriff (PDF)

Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden

Drug and alcohol dependence, 2021-07, Vol.224, p.108729-108729, Article 108729

2021

Volltextzugriff (PDF)

Characteristics of Unclaimed Prescriptions in a College-Aged Population

Journal of American college health, 2022, Vol.70 (1), p.34-38

2022

Volltextzugriff (PDF)

Exploring Patient Perceptions of Opioid Treatment Agreements in a Community Health Center Environment

Pain medicine (Malden, Mass.), 2021-04, Vol.22 (4), p.970-978

2021

Volltextzugriff (PDF)

Importance of the Pharmacist Perspective in Conversations About Medical Aid-in-Dying

Journal of general internal medicine : JGIM, 2020-02, Vol.35 (2), p.595-595

2020

Volltextzugriff (PDF)

Bridging pharmacy practice and research

Journal of the American Pharmacists Association, 2016-07, Vol.56 (4), p.356-357

Irwin, Adriane N

2016

Volltextzugriff (PDF)

Evaluation of Warfarin Use in Patients With Mental Health Conditions in a Rural Community Health Center System

The Journal of pharmacy technology, 2021-02, Vol.37 (1), p.17-22

2021

Volltextzugriff (PDF)

Understanding barriers to prescription retrieval and attitudes toward mental health medications at a university student health services pharmacy

Journal of the American Pharmacists Association, 2021-07, Vol.61 (4), p.S17-S24

2021

Volltextzugriff (PDF)

Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879

Journal of the American Pharmacists Association, 2019-07, Vol.59 (4), p.S112-S116

2019

Volltextzugriff (PDF)

Eteplirsen for the Treatment of Duchenne Muscular Dystrophy: Quality of Evidence Concerns—an Alternative Viewpoint

Pharmacotherapy, 2017-10, Vol.37 (10), p.e109-e111

2017

Volltextzugriff (PDF)

FDA Breakthrough Therapy Designation: Evaluating the Quality of the Evidence behind the Drug Approvals

Pharmacotherapy, 2018-09, Vol.38 (9), p.967-980

2018

Volltextzugriff (PDF)

Implementation of a pharmacist-delivered Medicare counseling service in a rural community health center

Journal of the American Pharmacists Association, 2020-07, Vol.60 (4), p.e79-e85

2020

Volltextzugriff (PDF)

Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains

Journal of the American Pharmacists Association, 2024-01, Vol.64 (1), p.71-78

2024

Volltextzugriff (PDF)

Understanding Oregon’s Public Health and Pharmacy Formulary Advisory Committee

Journal of the American Pharmacists Association, 2021-03, Vol.61 (2), p.e57-e60

2021

Volltextzugriff (PDF)

Pharmacist experiences and perspectives with Oregon’s Death with Dignity Act

Journal of the American Pharmacists Association, 2020-11, Vol.60 (6), p.874-879.e1

2020

Volltextzugriff (PDF)

Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies

Substance abuse, 2022, Vol.43 (1), p.901-905

2022

Volltextzugriff (PDF)

Impact of the RESPOND Toolkit on community pharmacists’ opioid safety attitudes, self-efficacy, and knowledge

Journal of the American Pharmacists Association, 2020-05, Vol.60 (3), p.450-455.e3

2020

Volltextzugriff (PDF)

Development and pilot of a prescription drug monitoring program and communication intervention for pharmacists

Research in social and administrative pharmacy, 2020-10, Vol.16 (10), p.1422-1430

2020

Volltextzugriff (PDF)

“I go out of my way to give them an extra smile now:” A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials

Research in social and administrative pharmacy, 2024-05, Vol.20 (5), p.512-519

2024

Volltextzugriff (PDF)

Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician

Journal of the American Pharmacists Association, 2023-01, Vol.63 (1), p.284-294.e1

2023

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(70)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(54)
Pharmacology & Pharmacy
(44)
Humans
(24)
Pharmacy
(14)
Pharmacists
(13)
Female
(11)
Pharmacies
(9)
Male
(7)
Naloxone
(7)
Public, Environmental & Occupational Health
(6)
Community Pharmacy Services
(5)
Drug Stores
(5)
Internal Medicine
(5)
Aged
(4)
Buprenorphine
(4)
Narcotics
(4)
Nonprescription Drugs
(4)
Opioids
(4)
Patients
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Psychosocial factors associated with pharmacists’ end-of-life medication counseling and dispensing

Educational Approach to Increase Student Pharmacist Confidence with Medicare

Assessing provider knowledge of the federal 340B Drug Pricing Program in a federally qualified health center

Characterization of kratom use and knowledge at a rural, Oregon community health center

Comparison of the time-to-indexing in PubMed between biomedical journals according to impact factor, discipline, and focus

Community pharmacies embedded within student health centers on college and university campuses: A cross-sectional survey

Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden

Characteristics of Unclaimed Prescriptions in a College-Aged Population

Exploring Patient Perceptions of Opioid Treatment Agreements in a Community Health Center Environment

Importance of the Pharmacist Perspective in Conversations About Medical Aid-in-Dying

Bridging pharmacy practice and research

Evaluation of Warfarin Use in Patients With Mental Health Conditions in a Rural Community Health Center System

Understanding barriers to prescription retrieval and attitudes toward mental health medications at a university student health services pharmacy

Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879

Eteplirsen for the Treatment of Duchenne Muscular Dystrophy: Quality of Evidence Concerns—an Alternative Viewpoint

FDA Breakthrough Therapy Designation: Evaluating the Quality of the Evidence behind the Drug Approvals

Implementation of a pharmacist-delivered Medicare counseling service in a rural community health center

Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains

Understanding Oregon’s Public Health and Pharmacy Formulary Advisory Committee

Pharmacist experiences and perspectives with Oregon’s Death with Dignity Act

Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies

Impact of the RESPOND Toolkit on community pharmacists’ opioid safety attitudes, self-efficacy, and knowledge

Development and pilot of a prescription drug monitoring program and communication intervention for pharmacists

“I go out of my way to give them an extra smile now:” A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials

Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician

Suchergebnisse filtern